← Leaderboards
Chafiq Hamdouchi
Indiana University Indianapolis
$903,832
Attributed
$1,807,663
Total exposure
1
Grants
0
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $474.6K · FY2022–25$500K$375K$250K$125K$0
'22
'23
'24
'25
Funding mix
By agency
NIH$1,807,663 · 1
By mechanism
R01$1,807,663 · 1
Top collaborators
- Chunhai Charlie Hao4 shared
Most similar at Indiana University Indianapolis
Same institution · by research overlap
- Karen Elizabeth Pollok$3,384,915
- Elliot J Androphy$24,340,128
- Rajesh Khanna$12,550,368
- Steven Michael Johnson$2,399,411
- Sara K Quinney$11,876,528
Others in their field
Other Rising Stars on “Absorption”
- Colin Osborne · University Of Texas Med Br Galveston$10,407,745
- Alexander Kolykhalov · Emory University$8,116,465
- Anil Gupta · Scripps Research Institute, The$7,340,144
- Debra Burnin · Sri International$7,194,143
- David Burkhart · Inimmune Corporation$5,907,864
- Moustafa Gabr · Weill Medical Coll Of Cornell Univ$5,835,304
Research focus
AbsorptionAbcb1 GeneAnalogAnticancer ActivityAntineoplastic AgentsAdverse EffectsBindingBinding ProteinsBiological AvailabilityBiological ProductsBlood-Brain Barrier PermeabilizationBrainBrain NeoplasmsCellsChemotherapyChemotherapy And/Or RadiationClinical ManagementClinical TreatmentClinical TrialsComplexComputational ChemistryCounterscreenCrispr/Cas TechnologyCul1 Gene
Grant awards (4)
Development of BBB-permeable SUMO1 small molecule degraders for glioblastoma therapy.$421,952
R01 · FY2025 · NS
Development of BBB-permeable SUMO1 small molecule degraders for glioblastoma therapy.$445,738
R01 · FY2024 · NS
Development of BBB-permeable SUMO1 small molecule degraders for glioblastoma therapy.$465,410
R01 · FY2023 · NS
Development of BBB-permeable SUMO1 small molecule degraders for glioblastoma therapy.$474,563
R01 · FY2022 · NS